LaPrincess C Brewer1, Sarah Jenkins2, Sharonne N Hayes3, Ashok Kumbamu3, Clarence Jones4, Lora E Burke5, Lisa A Cooper6, Christi A Patten7. 1. Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN; Center for Health Equity and Community Engagement Research, Mayo Clinic, Rochester, MN. Electronic address: brewer.laprincess@mayo.edu. 2. Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. 3. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN. 4. Hue-Man Partnership, Minneapolis, MN. 5. School of Nursing, Department of Health and Community Systems, University of Pittsburgh, Pittsburgh, PA. 6. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 7. Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN.
Abstract
BACKGROUND: Compared to whites, African-Americans have lower prevalence of ideal cardiovascular health (CVH) based on the American Heart Association Life's Simple 7 (LS7). These CVH inequities have worsened during the COVID-19 pandemic. Ideal LS7 health-promoting behaviors and biological risk factors (eg, diet, blood pressure) are associated with improved CVH outcomes. The FAITH! (Fostering African-American Improvement in Total Health) App, a community-informed, mobile health (mHealth) intervention, previously demonstrated significant improvements in LS7 components among African-Americans, suggesting that mHealth interventions may be effective in improving CVH. This paper presents the FAITH! Trial design, baseline findings, and pandemic-related lessons learned. METHODS: Utilizing a community-based participatory research approach, this study assessed the feasibility/preliminary efficacy of a refined FAITH! App for promoting LS7 among African-Americans in faith communities using a cluster, randomized controlled trial. Participants received the FAITH! App (immediate intervention) or were assigned to a delayed intervention comparator group. Baseline data were collected via electronic surveys and health assessments. Primary outcomes are change in LS7 score from baseline to 6-months post-intervention and app engagement/usability. RESULTS: Of 85 enrolled individuals, 76 completed baseline surveys/health assessments, for a participation rate of 89% (N = 34 randomized to the immediate intervention, N = 42 to delayed intervention). At baseline, participants were predominantly female (54/76, 71%), employed (56/76, 78%) and of high cardiometabolic risk (72/76, 95% with hypertension and/or overweight/obesity) with mean LS7 scores in the poor range (6.8, SD = 1.9). CONCLUSIONS: The FAITH! Trial recruitment was feasible, and its results may inform the use of mHealth tools to increase ideal CVH among African-Americans.
BACKGROUND: Compared to whites, African-Americans have lower prevalence of ideal cardiovascular health (CVH) based on the American Heart Association Life's Simple 7 (LS7). These CVH inequities have worsened during the COVID-19 pandemic. Ideal LS7 health-promoting behaviors and biological risk factors (eg, diet, blood pressure) are associated with improved CVH outcomes. The FAITH! (Fostering African-American Improvement in Total Health) App, a community-informed, mobile health (mHealth) intervention, previously demonstrated significant improvements in LS7 components among African-Americans, suggesting that mHealth interventions may be effective in improving CVH. This paper presents the FAITH! Trial design, baseline findings, and pandemic-related lessons learned. METHODS: Utilizing a community-based participatory research approach, this study assessed the feasibility/preliminary efficacy of a refined FAITH! App for promoting LS7 among African-Americans in faith communities using a cluster, randomized controlled trial. Participants received the FAITH! App (immediate intervention) or were assigned to a delayed intervention comparator group. Baseline data were collected via electronic surveys and health assessments. Primary outcomes are change in LS7 score from baseline to 6-months post-intervention and app engagement/usability. RESULTS: Of 85 enrolled individuals, 76 completed baseline surveys/health assessments, for a participation rate of 89% (N = 34 randomized to the immediate intervention, N = 42 to delayed intervention). At baseline, participants were predominantly female (54/76, 71%), employed (56/76, 78%) and of high cardiometabolic risk (72/76, 95% with hypertension and/or overweight/obesity) with mean LS7 scores in the poor range (6.8, SD = 1.9). CONCLUSIONS: The FAITH! Trial recruitment was feasible, and its results may inform the use of mHealth tools to increase ideal CVH among African-Americans.
Authors: Lorenda Belone; Julie E Lucero; Bonnie Duran; Greg Tafoya; Elizabeth A Baker; Domin Chan; Charlotte Chang; Ella Greene-Moton; Michele A Kelley; Nina Wallerstein Journal: Qual Health Res Date: 2014-10-31
Authors: Don Bambino Geno Tai; Aditya Shah; Chyke A Doubeni; Irene G Sia; Mark L Wieland Journal: Clin Infect Dis Date: 2021-02-16 Impact factor: 9.079
Authors: Selina A Smith; Mary S Whitehead; Joyce Q Sheats; Benjamin E Ansa; Steven S Coughlin; Daniel S Blumenthal Journal: J Ga Public Health Assoc Date: 2015
Authors: Teresa C Carithers; Sameera A Talegawkar; Marjuyua L Rowser; Olivia R Henry; Patricia M Dubbert; Margaret L Bogle; Herman A Taylor; Katherine L Tucker Journal: J Am Diet Assoc Date: 2009-07
Authors: LaPrincess C Brewer; Sarah Jenkins; Sharonne N Hayes; Ashok Kumbamu; Clarence Jones; Lora E Burke; Lisa A Cooper; Christi A Patten Journal: Circulation Date: 2022-07-18 Impact factor: 39.918
Authors: LaPrincess C Brewer; Jissy Cyriac; Ashok Kumbamu; Lora E Burke; Sarah Jenkins; Sharonne N Hayes; Clarence Jones; Lisa A Cooper; Christi A Patten Journal: Digit Health Date: 2022-07-18
Authors: Jesse Enebi Usman; Charmaine Childs; David Rogerson; Markos Klonizakis Journal: Int J Environ Res Public Health Date: 2022-07-21 Impact factor: 4.614